Eric M Stone

Personalized, evidence-based autism therapy—accessible everywhere. We’re eliminating barriers to ABA therapy by connecting children to Master’s and PhD-level therapists through our easy-to-use virtual platform.

Derived from the Finnish word for “to serve”, Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases, we believe we can dramatically enhance quality of life.

At Kapor Capital, we invest in seed stage startups that close gaps of access, expand economic opportunity and make a positive impact in our society and the economy. Our entrepreneurs come from all backgrounds, with a special focus on people of color, women, and other historically underrepresented groups who are inspired by their lived experience to shape the future and inform the questions they ask and the problems they identify that give rise to profitable, tech-driven solutions. We are an Oakland-based fund that understands that start-up companies have the ability to transform entire industries and believe that startups can leverage information technology to solve real world problems and tangibly improve the lives of millions through innovations in the fields of education, finance, health, work, justice and more.

Personalized, evidence-based autism therapy—accessible everywhere. We’re eliminating barriers to ABA therapy by connecting children to Master’s and PhD-level therapists through our easy-to-use virtual platform.

Derived from the Finnish word for “to serve”, Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases, we believe we can dramatically enhance quality of life.

Velano Vascular is transforming the inpatient experience with the PIVO™, a breakthrough needle-free blood collection device. PIVO aims to reduce painful needle sticks for inpatients, to improve practitioner safety, and to provide hospitals with a smarter financial solution for vascular access. Velano is backed by leading U.S. health systems including Sutter Health, Griffin Hospital and The Children's Hospital of Philadelphia, as well as First Round Capital, Kapor Capital, White Owl Capital, Safeguard Scientifics and dozens of heath industry veterans. Velano collaborates with innovators in patient-centered care, including Planetree, Intermountain Healthcare, Brigham & Women's Hospital and more. Our mission is to establish a new, more humane standard of care. We're looking for bright, tenacious candidates to join our incredible team of business and healthcare professionals. Check out our careers page here: http://velanovascular.com/careers/

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy